adesso SE

XTRA:ADN1 Aktierapport

Börsvärde: €388.3m

adesso Tidigare resultatutveckling

Tidigare kriterier kontrolleras 2/6

adesso s intäkter har minskat med en genomsnittlig årlig takt på -43.3%, medan IT -branschen såg intäkter på växande på 6.1% årligen. Intäkterna har varit växande med en genomsnittlig takt på 19% per år. adesso s avkastning på eget kapital är 14% och den har en nettomarginal på 1.8%.

Viktig information

-43.28%

Tillväxttakt i vinsten

-44.10%

Tillväxttakt för EPS

IT Tillväxt i branschen13.97%
Intäkternas tillväxttakt19.01%
Avkastning på eget kapital13.99%
Nettomarginal1.77%
Nästa resultatuppdatering14 Aug 2026

Senaste uppdateringar av tidigare prestationer

Analysartikel Apr 07

Shareholders Can Be Confident That adesso's (ETR:ADN1) Earnings Are High Quality

When companies post strong earnings, the stock generally performs well, just like adesso SE's ( ETR:ADN1 ) stock has...

Recent updates

Uppdatering av berättelse May 23

ADN1: 2026 Guidance And Dividend Outlook Will Support Future Upside Potential

Analysts have trimmed their price target for adesso from about €107.67 to about €103.33, pointing to shifts in model assumptions around the discount rate, revenue growth, profit margins and future P/E as the key drivers behind the change. What's in the News adesso SE reaffirmed its earnings guidance for fiscal 2026, citing sustained demand for digitalisation projects despite the German government assessing weaker recovery trends for the German economy in 2026, particularly linked to energy prices (Corporate Guidance).
Uppdatering av berättelse May 09

ADN1: 2026 Earnings Guidance And Dividend Policy Will Support Future Upside Potential

Analysts have reduced their price target on adesso from €114.17 to €107.67, citing slightly revised revenue growth and P/E assumptions along with a modestly higher profit margin outlook. What's in the News adesso reaffirmed earnings guidance for 2026, with expected revenues in a range of €1.6b to €1.7b and guidance that EBIT margin is expected to show only a little improvement in 2026 (Corporate Guidance).
Uppdatering av berättelse Apr 24

ADN1: Higher Discount Rate Will Create Long Term Opportunity

Analysts have reduced their price target on adesso from €160 to €140, citing updated assumptions for a higher discount rate, slightly lower revenue growth and profit margin expectations, and a higher future P/E multiple. What's in the News adesso SE reaffirmed earnings guidance for 2026, with expected revenues in a range between €1.6b and €1.7b and only a little improvement in the EBIT margin in that year (Corporate Guidance).
Uppdatering av berättelse Apr 10

ADN1: Dividend Visibility And Expanded Partnership Will Support Future Upside Potential

Analysts have trimmed their price target for adesso from about €127.83 to about €114.17. They now apply a higher discount rate, slightly lower revenue growth and profit margin assumptions, and a higher future P/E multiple in their models.
Analysartikel Apr 07

Shareholders Can Be Confident That adesso's (ETR:ADN1) Earnings Are High Quality

When companies post strong earnings, the stock generally performs well, just like adesso SE's ( ETR:ADN1 ) stock has...
Analysartikel Feb 12

The Price Is Right For adesso SE (ETR:ADN1) Even After Diving 28%

The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 28%. Instead...
Analysartikel Jan 22

adesso (ETR:ADN1) Seems To Use Debt Quite Sensibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysartikel Oct 19

Is There Now An Opportunity In adesso SE (ETR:ADN1)?

adesso SE ( ETR:ADN1 ), is not the largest company out there, but it saw a significant share price rise of 23% in the...
Analysartikel Sep 12

A Piece Of The Puzzle Missing From adesso SE's (ETR:ADN1) 32% Share Price Climb

adesso SE ( ETR:ADN1 ) shareholders would be excited to see that the share price has had a great month, posting a 32...
Analysartikel Sep 10

Here's What's Concerning About adesso's (ETR:ADN1) Returns On Capital

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analysartikel May 25

Solid Earnings Reflect adesso's (ETR:ADN1) Strength As A Business

adesso SE's ( ETR:ADN1 ) earnings announcement last week was disappointing for investors, despite the decent profit...
Analysartikel Feb 25

adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.75

The board of adesso SE ( ETR:ADN1 ) has announced that the dividend on 6th of June will be increased to €0.75, which...
User avatar
Ny berättelse Feb 07

Ongoing IT Investments Will Transform Operations By Mid-2025

Organic growth in healthcare and utilities drives future revenue, overcoming economic challenges, while strategic share buybacks reflect belief in undervaluation.
Analysartikel Dec 02

Investors Still Aren't Entirely Convinced By adesso SE's (ETR:ADN1) Revenues Despite 32% Price Jump

adesso SE ( ETR:ADN1 ) shares have continued their recent momentum with a 32% gain in the last month alone. Not all...
Analysartikel Nov 22

adesso (ETR:ADN1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Investors signalled that they were pleased with adesso SE's ( ETR:ADN1 ) most recent earnings report. Looking deeper at...
Analysartikel Nov 17

adesso SE (ETR:ADN1) Just Reported, And Analysts Assigned A €122 Price Target

The investors in adesso SE 's ( ETR:ADN1 ) will be rubbing their hands together with glee today, after the share price...
Analysartikel Nov 02

Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysartikel Aug 28

It's Down 25% But adesso SE (ETR:ADN1) Could Be Riskier Than It Looks

The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 25%. Instead...
Analysartikel May 21

adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year

The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...
Analysartikel Apr 19

adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70

The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...
Analysartikel Apr 18

Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysartikel Apr 02

Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality

The market for adesso SE's ( ETR:ADN1 ) shares didn't move much after it posted weak earnings recently. We did some...
Analysartikel Mar 28

Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results

Last week saw the newest full-year earnings release from adesso SE ( ETR:ADN1 ), an important milestone in the...
Analysartikel Mar 23

Is adesso SE (ETR:ADN1) Trading At A 44% Discount?

Key Insights adesso's estimated fair value is €193 based on 2 Stage Free Cash Flow to Equity Current share price of...
Analysartikel Mar 08

adesso SE (ETR:ADN1) Soars 29% But It's A Story Of Risk Vs Reward

adesso SE ( ETR:ADN1 ) shares have had a really impressive month, gaining 29% after a shaky period beforehand. Not all...
Analysartikel Dec 14

A Look At The Intrinsic Value Of adesso SE (ETR:ADN1)

Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €95.16 With €91.00 share price...
Analysartikel Oct 11

Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysartikel Jul 22

At €106, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?

adesso SE ( ETR:ADN1 ), might not be a large cap stock, but it received a lot of attention from a substantial price...
Analysartikel Jun 15

Calculating The Intrinsic Value Of adesso SE (ETR:ADN1)

Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €146 With €123 share price...
Analysartikel May 09

adesso's (ETR:ADN1) Returns On Capital Not Reflecting Well On The Business

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Analysartikel Apr 22

What Does adesso SE's (ETR:ADN1) Share Price Indicate?

While adesso SE ( ETR:ADN1 ) might not be the most widely known stock at the moment, it saw significant share price...
Analysartikel Feb 11

adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysartikel Jan 26

Returns On Capital At adesso (ETR:ADN1) Have Stalled

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

Fördelning av intäkter och kostnader

Hur adesso tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.


Resultat- och intäktshistorik

XTRA:ADN1 Intäkter, kostnader och resultat (EUR Millions )
DatumIntäkterIntäkterG+A KostnaderFoU-kostnader
31 Mar 261,53727270
31 Dec 251,48918270
30 Sep 251,4235250
30 Jun 251,3794250
31 Mar 251,335-1250
31 Dec 241,2983250
30 Sep 241,2695200
30 Jun 241,225-1200
31 Mar 241,182-2200
31 Dec 231,1403200
30 Sep 231,0845160
30 Jun 231,03712160
31 Mar 2396918160
31 Dec 2290129160
30 Sep 2283629110
30 Jun 2276928110
31 Mar 2272537110
31 Dec 2167848110
30 Sep 216364590
30 Jun 216004690
31 Mar 215644290
31 Dec 205242190
30 Sep 205032440
30 Jun 204841990
31 Mar 204671890
31 Dec 194511790
30 Sep 1943215110
30 Jun 1941213140
31 Mar 1939513140
31 Dec 1837814140
30 Sep 1836414140
30 Jun 1835114140
31 Mar 1833613140
31 Dec 1732211140
30 Sep 1730711130
30 Jun 1729211120
31 Mar 1727612120
31 Dec 1626112120
30 Sep 1624510100
30 Jun 16229790
31 Mar 16213690
31 Dec 15197590
30 Sep 15183470
30 Jun 15169440

Kvalitetsintäkter: ADN1 har inkomster av hög kvalitet.

Växande vinstmarginal: ADN1 blev lönsam tidigare.


Fritt kassaflöde vs resultatanalys


Analys av tidigare vinsttillväxt

Resultatutveckling: ADN1 s intäkter har minskat med 43.3% per år under de senaste 5 åren.

Accelererande tillväxt: ADN1 har blivit lönsamt under det senaste året, vilket gör det svårt att jämföra vinsttillväxttakten med 5-årsgenomsnittet.

Resultat vs industri: ADN1 har blivit lönsamt under det senaste året, vilket gör det svårt att jämföra det senaste årets vinsttillväxt med IT branschen ( 4% ).


Avkastning på eget kapital

Hög ROE: ADN1 s avkastning på eget kapital ( 14% ) anses vara låg.


Avkastning på tillgångar


Avkastning på sysselsatt kapital


Upptäck starka bolag som tidigare presterat bra

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/05/31 09:32
Aktiekurs vid dagens slut2026/05/29 00:00
Intäkter2026/03/31
Årlig intjäning2025/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

adesso SE bevakas av 11 analytiker. 6 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Daniel GroßjohannBankM AG
Wolfgang SpechtBerenberg
Finn KemperHauck Aufhäuser Investment Banking